of borderline significanceP = 0.05
However, a double-blind randomized controlled trial by the same group enrolling 52 patients could not confirm the effect of mannitol administration on SBP decline during dialysis sessions and the decrease in IDH risk was of borderline significance (P = 0.05) [ 110 ].